相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura
Celine Comparon et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2023)
Health following recovery from immune thrombotic thrombocytopenic purpura: the patient's perspective
Rachel A. Kelley et al.
BLOOD ADVANCES (2023)
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease
Zulqarnain Javed et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2022)
Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission
Senthil Sukumar et al.
BLOOD ADVANCES (2022)
Daratumumab for immune thrombotic thrombocytopenic purpura
Jana van den Berg et al.
BLOOD ADVANCES (2022)
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura
Jenna Brown et al.
ANNALS OF HEMATOLOGY (2022)
How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge
Frank Akwaa et al.
BLOOD (2022)
Race, rituximab, and relapse in TTP
Shruti Chaturvedi et al.
BLOOD (2022)
Health Disparities Across the Continuum of ASCVD Risk
Ankita Devareddy et al.
CURRENT CARDIOLOGY REPORTS (2022)
Bortezomib, a promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment
Jie Yin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition
Jia Yu et al.
BLOOD (2022)
Intensive rituximab regimen in immune-mediated thrombotic thrombocytopenic purpura can circumvent unresponsiveness to standard rituximab treatment
Christophe Barba et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Redefining outcomes in immune TTP: an international working group consensus report
Adam Cuker et al.
BLOOD (2021)
Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura
Max A. Brodsky et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study
Francesca Schieppati et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura
Pasquale Agosti et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
X. Long Zheng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival
Renaud Prevel et al.
BLOOD (2019)
Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors
Harshvardhan Upreti et al.
BLOOD (2019)
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
Lova Sun et al.
BLOOD ADVANCES (2019)
Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis
Kemar Prussien et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2019)
Antiplatelet agents for preventing pre-eclampsia and its complications
Lelia Duley et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
Matthieu Jestin et al.
BLOOD (2018)
Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura
Kathryn Dane et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
TTP: long-term outcomes following recovery
James N. George
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics
M. Saha et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study)
Sigurdur Sigurdsson et al.
STROKE (2017)
Post-traumatic stress disorder and depression in survivors of thrombotic thrombocytopenic purpura
Shruti Chaturvedi et al.
THROMBOSIS RESEARCH (2017)
Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura
Tanja Falter et al.
TRANSFUSION (2017)
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015
Evaren E. Page et al.
BLOOD ADVANCES (2017)
Morbidity and mortality associated with obesity
Mahmoud Abdelaal et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Von Willebrand Factor, ADAMTS13, and the Risk of Mortality The Rotterdam Study
Michelle A. H. Sonneveld et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
Evaren E. Page et al.
BLOOD (2016)
Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study
M. A. H. Sonneveld et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Von Willebrand factor regulates complement on endothelial cells
Damien G. Noone et al.
KIDNEY INTERNATIONAL (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Silent Brain Infarction and Risk of Future Stroke A Systematic Review and Meta-Analysis
Ajay Gupta et al.
STROKE (2016)
Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
Suella Martino et al.
PLOS ONE (2016)
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura
Bowie Han et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Increased morbidity during long-term follow-up of survivors of thrombotic thrombocytopenic purpura
Shruti Chaturvedi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura
Wendy Lim et al.
BLOOD (2015)
Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
M. A. H. Sonneveld et al.
BLOOD (2015)
Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy
S. K. Vesely
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
Melanie Roriz et al.
MEDICINE (2015)
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Miguel Hie et al.
BLOOD (2014)
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura
Yang Jiang et al.
BLOOD (2014)
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes
Marie Scully et al.
BLOOD (2014)
Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura
Marshall A. Mazepa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Depression and cardiovascular disease: a clinical review
David L. Hare et al.
EUROPEAN HEART JOURNAL (2014)
Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case? control study
Barbara Ferrari et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Thrombotic Microangiopathies and the Linkage between von Willebrand Factor and the Alternative Complement Pathway
Nancy Turner et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
Sarka Lisonkova et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 20002004
Candace H. Feldman et al.
ARTHRITIS AND RHEUMATISM (2013)
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura
Cassandra C. Deford et al.
BLOOD (2013)
Hypertensive disease of pregnancy and maternal mortality
Jamie O. Lo et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2013)
Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia
Salah Aref et al.
HEMATOLOGY (2013)
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories A Systematic Review and Meta-analysis
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
Jake Shortt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model
Sheng-Yu Jin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice
Chintan Gandhi et al.
BLOOD (2012)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
Francois Beloncle et al.
TRANSFUSION (2012)
Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura
Spero R. Cataland et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Von Willebrand Factor and ADAMTS13 A Candidate Couple for Preeclampsia Pathophysiology
Alain Stepanian et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy
Rachna Raman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Overweight, Obesity, and Depression A Systematic Review and Meta-analysis of Longitudinal Studies
Floriana S. Luppino et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
Huichun Zhan et al.
TRANSFUSION (2010)
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Gary Whitlock et al.
LANCET (2009)
Hypertensive Disorders and Severe Obstetric Morbidity in the United States
Elena V. Kuklina et al.
OBSTETRICS AND GYNECOLOGY (2009)
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies
Elena Bresin et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura
April S. Kennedy et al.
TRANSFUSION (2009)
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura
Qurana F. Lewis et al.
TRANSFUSION (2009)
Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004
Anne B. Wallis et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
Ming Jin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
Flora Peyvandi et al.
HAEMATOLOGICA (2008)
Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry
James N. George et al.
JOURNAL OF CLINICAL APHERESIS (2008)
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis
Hendrik B. Feys et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow
A Bernardo et al.
BLOOD (2004)
Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies
AS Ducloy-Bouthors et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2003)
A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group
MA Howard et al.
JOURNAL OF CLINICAL APHERESIS (2003)
Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura
NA Aqui et al.
JOURNAL OF CLINICAL APHERESIS (2003)
Neuropsychological aspects of pediatric sickle cell disease
MC Kral et al.
NEUROPSYCHOLOGY REVIEW (2001)
分享论文
